34 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
6 Nov 19
Zafgen Reports Third Quarter 2019 Financial Results
4:30pm
reductions in workforce and contract termination costs implemented in the third quarter of 2019.
General and Administrative Expenses
General
8-K
EX-99.1
8qmdszb
5 Mar 20
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm
PRE 14A
teklccuu3d o0v
12 Apr 24
Preliminary proxy
6:06am